Form 4: CERUS Director Jami Nachtsheim Granted 60,000 Restricted Stock Units

CERUS Corporation Director Jami K. Nachtsheim was granted 60,000 Restricted Stock Units (RSUs) on June 3, 2025, increasing her total beneficial ownership to 208,362 shares.

Summary

• Jami K. Nachtsheim, a Director of CERUS Corporation (CERS), acquired 60,000 shares of common stock on June 3, 2025.
• The acquisition was made at a price of $0 per share, indicating a grant rather than a purchase.
• These shares represent Restricted Stock Units (RSUs) granted pursuant to the Issuer's 2024 Equity Incentive Plan.
• Each RSU signifies a contingent right to receive one share of CERUS common stock.
• The RSUs are scheduled to vest on the earlier of the first anniversary of the grant date or the day prior to the next annual meeting of stockholders, contingent upon Ms. Nachtsheim's continuous service to the Issuer.
• Following this transaction, Ms. Nachtsheim's total beneficial ownership of CERUS common stock stands at 208,362 shares.

Sentiment

Score: 7

Explanation: The document reports a standard equity grant to a director, which is a positive for aligning interests and retention, but does not contain significant new financial or operational news to dramatically shift sentiment. It's a routine corporate governance item.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This equity award is part of the company's 2024 Equity Incentive Plan, indicating a structured and ongoing approach to executive and director compensation and retention.

Risks

• The actual value realized by the director from the RSUs upon vesting is subject to the future market price of CERUS Corporation's common stock, which could be lower than the current value if the stock price declines.
• Vesting of the RSUs is contingent upon the director's continuous service to the Issuer, meaning the shares will not be received if service is terminated before the vesting date.

Future Outlook

The future outlook related to this filing indicates that the 60,000 Restricted Stock Units granted will vest and convert into common stock shares on the earlier of June 3, 2026 (the first anniversary of the grant date) or the day prior to the next annual meeting of stockholders, provided the director maintains continuous service.

Industry Context

Equity grants, such as Restricted Stock Units (RSUs), are a prevalent form of compensation within the biotechnology and medical device sectors, where CERUS Corporation operates. These grants are strategically utilized to attract, retain, and incentivize key personnel, including directors, by aligning their financial interests with the long-term performance and shareholder value creation of the company.

Comparison to Industry Standards

• The use of RSU grants as a form of director compensation is a standard practice across publicly traded companies, including those in the biotech and healthcare industries.
• Companies such as Gilead Sciences, Amgen, and Illumina frequently employ similar equity incentive plans to compensate their directors and executives, with grant sizes typically varying based on the company's market capitalization, the individual's role, and specific performance metrics.
• The $0 acquisition price for the RSUs is typical for compensation awards, as these units represent a contingent right to receive shares as part of a compensation package rather than a direct cash purchase.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders, as the value of the compensation is directly tied to the company's stock performance, potentially encouraging decisions that enhance long-term shareholder value. It also contributes to the retention of key board members.
• Employees: While this specific grant is to a director, the utilization of the 2024 Equity Incentive Plan suggests a broader framework for equity-based compensation, which can positively impact overall employee morale and retention by demonstrating a commitment to shared success.

Next Steps

• The 60,000 RSUs granted to Director Jami K. Nachtsheim are expected to vest on the earlier of June 3, 2026, or the day prior to the next annual meeting of stockholders, subject to continuous service.

Key Dates

Recommendation

Keywords

CERUS Corporation, CERS, Form 4, SEC filing, Restricted Stock Units, RSUs, Equity Incentive Plan, Insider Transaction, Director Compensation, Stock Grant